News

AddToAny

Google+ Facebook Twitter Twitter

"Trust and inequality fuelling COVID-19 spread"

Trust in public institutions is linked to fewer COVID-19 deaths – however, trust and belonging to groups is associated with more deaths.

This is the finding of a wide-ranging study of 30-day COVID-19 mortality rates in 84 countries. 

Greater economic inequality is also associated with COVID-19 mortality, the results show.

The study is the first to show how global differences in COVID-19 mortality relate to income inequality. 

It also includes surveys on social trust and confidence in public institutions representing 86% of the global population.

The analysis reveals that COVID-19 mortality is linked to differences in trust. 

A lack of confidence in state institutions was associated with more deaths – consistent with research during the SARS and H1N1 pandemics.

However, the researchers found that social trust and belonging is also associated with mortality. 

While connecting with friends and family is a natural response in times of crisis, in some countries, this trust and the desire to socialise may be interfering with efforts to contain transmission through physical distancing.

Moreover, strong group bonds can sometimes reinforce risky health behaviours, so that high-trusting societies may be more susceptible to misinformation about the severity of COVID-19, bogus treatments, or dismissive attitudes towards physical distancing. 

bit.ly/2SEdseA

Image Credit | GettyImages

Related Articles

Medical Science Laboratory with Diverse Multi-Ethnic Team of Microbiology Scientists Have Meeting on Developing Drugs, Medicine, Doing Biotechnology Research-CREDIT_istock-1293772951

Equity, diversity and inclusion for all

Jemma Shead, a Senior Biomedical Scientist at Synnovis and IBMS EDI Working Group member, on how and why you should get involved with EDI.

adeno associated virus capsid-Image Credit | Science Photo Library - c0142837

Examining the medical mystery of child hepatitis outbreak

A study has shed light on an unexpected wave of severe acute hepatitis cases in 2022, amid the backdrop of the ongoing global COVID-19 pandemic.

clostridioides difficile bacteria-Image Credit | Science Photo Library - c0016337

Faecal microbiota transplant for C. diff

In the first comprehensive US evidence-based guideline on the use of faecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological Association recommends faecal microbiota transplant (FMT) for most patients with recurrent Clostridioides difficile (C. diff) infection.

pseudomonas aeruginosa bacteria Image-Credit | Science Photo Library - f0381226

Tackling priority pathogen with phages

A new study describes the use of phage therapy to eradicate multidrug-resistant Pseudomonas aeruginosa infections in vivo with important new implications for antibiotic resistance.

Top